Načítá se...
Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD
OBJECTIVE: To investigate whether aquaporin-4–immunoglobulin G (AQP4-IgG) titers and measures of complement-mediated cell killing are clinically useful to predict the occurrence of relapse, relapse severity, and/or disability in neuromyelitis optica spectrum disorder (NMOSD). METHODS: We studied 336...
Uloženo v:
| Vydáno v: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7286655/ https://ncbi.nlm.nih.gov/pubmed/35413004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000727 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|